Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

DiMe Publications

FDA Diversity Plan Clinical Trials


A letter submitted on behalf of the Digital Medicine Society (DiMe) for consideration by the U.S. Food and Drug Administration (FDA) regarding Docket No. FDA-2021-D-0789 for “Diversity Plans to Improve Enrollment of Participants from Underrepresented Racial and Ethnic Populations in Clinical Trials; Draft Guidance for Industry; Availability .”

June 2022

View DiMe Comment

Share This Page

Copyright © 2022 The Digital Medicine Society (DiMe). All Rights Reserved.
×